The current stage of cathepsin B inhibitors as potential anticancer agents

作者: Janko Kos , Ana Mitrović , Bojana Mirković

DOI: 10.4155/FMC.14.73

关键词:

摘要: Cathepsin B is a lysosomal cysteine peptidase, with an important role in the development and progression of cancer. It involved degradation extracellular matrix proteins, process promoting invasion metastasis tumor cells angiogenesis. unique among cathepsins possessing both carboxypeptidase endopeptidase activities. While former associated its physiological role, latter pathological matrix. Its activities are regulated by different means, most being endogenous inhibitors, cystatins. In cancer this peptidase/inhibitor balance altered, leading to harmful cathepsin activity. The can be prevented exogenous inhibitors. They differ modes inhibition, size, structure, binding affinity, selectivity, toxicity bioavailability. article, we review properties function inhibitors indicate their appl...

参考文章(165)
Dejan Caglič, Jerica Rozman Pungerčar, Gunnar Pejler, Vito Turk, Boris Turk, Glycosaminoglycans facilitate procathepsin B activation through disruption of propeptide-mature enzyme interactions. Journal of Biological Chemistry. ,vol. 282, pp. 33076- 33085 ,(2007) , 10.1074/JBC.M705761200
Roger A. Smith, Peter J. Coles, Robin W. Spencer, Leslie J. Copp, Christopher S. Jones, Allen Krantz, Peptidyl O-acyl hydroxamates: Potent new inactivators of cathepsin B† Biochemical and Biophysical Research Communications. ,vol. 155, pp. 1201- 1206 ,(1988) , 10.1016/S0006-291X(88)81267-1
Kazunori HANADA, Masaharu TAMAI, Michio YAMAGISHI, Sadafumi OHMURA, Jiro SAWADA, Ichiro TANAKA, Isolation and Characterization of E–64, a New Thiol Protease Inhibitor Agricultural and biological chemistry. ,vol. 42, pp. 523- 528 ,(1978) , 10.1271/BBB1961.42.523
Izidor Sosič, Bojana Mirković, Samo Turk, Bogdan Štefane, Janko Kos, Stanislav Gobec, Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B. European Journal of Medicinal Chemistry. ,vol. 46, pp. 4648- 4656 ,(2011) , 10.1016/J.EJMECH.2011.08.005
Rodrigo L.O.R. Cunha, Miriam E. Urano, Jair R. Chagas, Paulo C. Almeida, Cláudia Bincoletto, Ivarne L.S. Tersariol, João V. Comasseto, Tellurium-based cysteine protease inhibitors: evaluation of novel organotellurium(IV) compounds as inhibitors of human cathepsin B. Bioorganic & Medicinal Chemistry Letters. ,vol. 15, pp. 755- 760 ,(2005) , 10.1016/J.BMCL.2004.11.012
Carmela Palermo, Johanna A. Joyce, Cysteine cathepsin proteases as pharmacological targets in cancer Trends in Pharmacological Sciences. ,vol. 29, pp. 22- 28 ,(2008) , 10.1016/J.TIPS.2007.10.011
Maxim Frizler, Friederike Lohr, Norbert Furtmann, Julia Kläs, Michael Gütschow, Structural Optimization of Azadipeptide Nitriles Strongly Increases Association Rates and Allows the Development of Selective Cathepsin Inhibitors Journal of Medicinal Chemistry. ,vol. 54, pp. 396- 400 ,(2011) , 10.1021/JM101272P
B Lenarčič, J Kos, I t Dolenc, P Lučovnik, I Križaj, V Turk, None, Cathepsin D inactivates cysteine proteinase inhibitors cystatins Biochemical and Biophysical Research Communications. ,vol. 154, pp. 765- 772 ,(1988) , 10.1016/0006-291X(88)90206-9
Roger A. Smith, Leslie J. Copp, Sheila L. Donnelly, Robin W. Spencer, Allen Krantz, Inhibition of cathepsin B by peptidyl aldehydes and ketones: slow-binding behavior of a trifluoromethyl ketone. Biochemistry. ,vol. 27, pp. 6568- 6573 ,(1988) , 10.1021/BI00417A056